Re-purposed hydroxychloroquine is being used for mild but high risk and moderate Covid-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday.
According to the data shared by the minister, the Department of Pharmaceuticals has increased the production of hydroxychloroquine manifold and the health ministry has issued 10.84 crore tablets of the drug to states and union territories as on September 11.
"India has also exported it (hydroxychloroquine) to more than 140 countries," Vardhan said.
He also said there is a plan to conduct trial of ayurvedic medicines such as aswagandha, guduchi, pippali etc to prevent people from getting infected from Covid-19.
The minister said no specific antivirals have been proven effective so far and symptomatic treatment for fever and cough, appropriate rehydration, supplemental oxygen therapy remains the mainstay of treatment.
The government has also made provisions for investigational therapies and has also made available Remdesivir, Convalescent plasma and Tocilizumab for managing severe cases under close medical supervision, Vardhan said.
Thirteen clinical trials of repurposed drugs and harnessing of traditional knowledge using the modern medicine are building a portfolio of therapeutic options for Covid-19 patients.
The minister said that more than 30 vaccine candidates have been supported which are in different stages of development, 3 candidates are in advanced stage of Phase I, II and III trials and more than 4 are in advanced pre-clinical development stage in India.
Source: PTI